Article Details
Retrieved on: 2022-01-17 17:01:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... cancer that was previously treated with an anti-HER2 regimen, according to a press release from developers Daiichi Sankyo and AstraZeneca.1.
Article found on: www.cancernetwork.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here